DARE BIOSCIENCE, INC. (DARE)
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil
General Announcement: Non-Binding Indicative Term Sheet for a Potential Strategic Joint Venture
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
Conduent Names Narayanan Sundaresan Chief Information and Technology Officer
Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
Liberty Star Minerals Engages Former Governor and U.S. Secretary of Energy Rick Perry as Critical Minerals Advisor to the Board of Directors
General Announcement: Request for Listing of Trading Halt - Sponsors Statement
Request for Lifting of Trading Halt: Request for Lifting of Trading Halt